Expands Cannepil License To Veterinary Therapeutics
29/07/2026 13:37
BRIEF-Splash Beverage Group - Expands Cannepil License To Veterinary Therapeutics July 29 (Reuters) - Splash Beverage Group Inc SBEV.A:
SPLASH BEVERAGE GROUP - EXPANDS CANNEPIL LICENSE TO VETERINARY THERAPEUTICS
SPLASH BEVERAGE GROUP - TO PURSUE FDA INAD AND CONDITIONAL APPROVAL FOR CANNEPIL VETERINARY USE
SPLASH BEVERAGE GROUP - TO PAY 10% ROYALTY TO ARGENT BIOPHARMA ON VETERINARY CANNEPIL REVENUES
SPLASH BEVERAGE GROUP - FINALIZING JOINT VENTURE FOR CANNEPIL VETERINARY DEVELOPMENT
Source text: ID:nGNX6RDkGK
Further company coverage: SBEV.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Endovia Health Sciences
See all newsBrief: Endovia Health Sciences - Enters Letter Agreement With C/M Capital Master Fund On Oct 15, 2026 - SEC Filing
Brief: Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026
Brief: Endovia Health Sciences Advances Cannepil FDA Submission, Expands Pipeline
Brief: Splash Beverage Reports Second Quarter 2026 Results And Highlights Strategic Transformation Toward Endovia Health Sciences
Expands Cannepil License To Veterinary Therapeutics